NDC 80425-0126-01 - Etodolac ER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0126
- Requested NDC
- 80425-0126-01
- Package NDCs from labels
- 80425-0126-1, 80425-0126-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Etodolac ER - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0126-1 | EtodolacER | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0126 | ETODOLAC ER (ETODOLAC) TABLET, EXTENDED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 1 package rows | 20250101_baebdfb2-17f6-9081-e053-2a95a90ab331.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0126-1 | EA - Each | 80425-0126 | 27df7106-302b-41a0-83af-ae6d695baa33 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Etodolac | ETODOLAC | Medsource Pharmaceuticals | 12f0685b-2127-d0d6-e063-6394a90a62d1 | 2024-03-05 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Aphena Pharma Solutions - Tennessee, LLC | 113558e6-8b45-cdbd-e063-6394a90ac036 | 2024-02-19 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Aphena Pharma Solutions - Tennessee, LLC | 1149072a-280a-2b11-e063-6394a90ac107 | 2024-02-19 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Aphena Pharma Solutions - Tennessee, LLC | 420b1ed5-e9f2-43dd-8d3c-ca9896221aca | 2024-01-29 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | A-S Medication Solutions | 06f602d1-6faf-41c8-bcfd-33e51f4ca636 | 2023-10-17 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Proficient Rx LP | e2fef939-2f4a-46ae-8177-073f5e8f57f5 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | A-S Medication Solutions | 31a55fb1-9721-4202-af7d-f06074b03102 | 2023-06-29 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | A-S Medication Solutions | 74baa6ad-b517-48e2-8cef-d77f5755b279 | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Proficient Rx LP | 0fce1aea-5de2-4acb-8a21-2b775c4adb25 | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Proficient Rx LP | 0c783997-6f2a-45ae-b899-c060c8be468a | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Doc Rx | cdde46e5-1123-410f-aafc-0c6e904a5d5b | 2021-09-28 | Boxed warning, Warnings, Adverse reactions | 2M36281008 |
| Etodolac | ETODOLAC | Proficient Rx LP | 4712e069-83b6-4052-8d95-f59ab1dba744 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 310245 2M36281008 |
| Etodolac | ETODOLAC | Proficient Rx LP | 449b273a-936a-4c49-b0c8-d0daa47733ae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | ANDA076174 310245 2M36281008 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.